Agoracom Blog Home

Posts Tagged ‘weed’

« Older Entries
Newer Entries »

PRIMO Nutraceuticals Inc. $PRMO.ca – What’s the difference between #CBD derived from #hemp and #cannabis? $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 10:45 AM on Monday, November 25th, 2019

SPONSOR:  PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

What’s the difference between CBD derived from hemp and cannabis?

By: Emma Ston

  • What’s in a name? When it comes to CBD products derived from hemp, CBD products derived from cannabis, and what’s considered legal, a lot.
  • Understanding cannabis nomenclature and the chemical difference between the two plants is essential to making informed choices about CBD.

Cannabis refers to a genus of plants which has three species: indica, sativa, and ruderalis. Hemp is not a different species of the cannabis plant. The above classifications have been devised to differentiate intoxicating cannabis from non-intoxicating cannabis. Hemp is a sativa species, while cannabis can be sativa, indica, or ruderalis.

Although hemp and cannabis look (sort of) similar, from a functional and chemical perspective, they are distinctive. Here’s how you can distinguish the two.

(Leafly)

Hemp:

  • In order to be federally legal, it must contain 0.3% THC or less. For the uninitiated, THC is the cannabinoid that causes a high. With so little THC, hemp doesn’t have intoxicating effects.
  • Can be used to create products such as textiles, building materials, industrial products, paper, foods, and body care.
  • Is typically grown outdoors to maximize the size and yield of the plant. Hemp doesn’t require the same rigorous attention to lighting, humidity, and temperature that cannabis requires, and it can be grown in a range of different climates.
  • Tends to be tall and skinny with skimpy foliage, having an appearance similar to bamboo.

Cannabis:

  • Can contain 0.3% THC or more. Some high-THC strains can have 30% THC or more.
  • Is used for recreational or medicinal purposes. You won’t find cannabis plants being used to create hempcrete or denim.
  • Is generally grown in carefully managed and controlled conditions. Photoperiodic cannabis requires precise exposure to light in order to flower—its buds contain the valuable, potent compounds cannabis is famed for.
  • Tends to appear bushy, with large, full foliage.

Here’s the tricky thing: Both cannabis and hemp produce CBD. The CBD molecule is identical regardless of its cannabis source. However, from a legal perspective, CBD products derived from hemp and CBD products derived from cannabis are entirely different.

Hemp-derived CBD and cannabis-derived CBD: A legal perspective

According to federal law, cannabis—with 0.3% THC content or higher—is classified by the DEA as a Schedule I drug with no accepted medical use. CBD products sourced from cannabis, even those with 0% THC, are illegal at a federal level by virtue of their plant origin. Here’s the tricky thing: Both cannabis and hemp produce CBD. The CBD molecule is identical regardless of its cannabis source.

However, at a state level, the law changes. There are 33 US states which have medical cannabis programs, and CBD derived from cannabis is available from a licensed dispensary to eligible patients. The recreational use of cannabis is also legal in 11 states. In these states, cannabis-derived CBD products are available to those of age.

Industrial hemp, on the other hand, is no longer considered a Schedule I controlled drug. Following the 2018 farm bill, hemp was reclassified as an agricultural commodity. Since then, there has been an explosion of CBD products onto the market, prompting the U.S. Food and Drug Administration (FDA) to issue a statement that a regulatory framework for CBD products is still in the pipeline, and foods containing CBD, dietary supplements, and products making health claims are considered illegal.

CBD products sourced from hemp, such as oils and tinctures, are legal at a federal level, so long as they conform with other applicable laws. That said, certain states have their own legislation and regulations regarding CBD oil.

If you want to purchase CBD and err on the right side of the law, verify the legal status of hemp-derived CBD and cannabis-derived CBD in your state, so you know what you can or can’t purchase. Generally, hemp-derived CBD represents the more legal option.

Other differences between hemp-derived CBD and cannabis-derived CBD

CBD concentration

Cannabis represents a richer source of cannabinoids and terpenes than industrial hemp because it contains significantly more resin. Resin is the sticky, gooey substance found on female cannabis flowers, and to a lesser extent, on its leaves. Hemp contains resin on the flowers and leaves too, but much less. Most industrial hemp cultivators need to grow large quantities of hemp to produce CBD oil, although there are now more CBD-rich hemp strains being cultivated.

Safety

Hemp is a bioaccumulator, so it can absorb toxins such as residual pesticides and heavy metals from soil. When CBD is extracted from large quantities of industrial hemp cultivated in non-organic conditions, there is a possibility that contaminant residue will be passed into the final product. CBD products sourced from tainted hemp can compromise safety and efficacy.

Regulation

The hemp-derived CBD market is not yet subject to a widely enforced regulatory framework. For this reason, it’s essential to do your homework when buying hemp-derived CBD.

Look out for hemp-derived CBD that has been third-party tested. Products that have undergone this have been checked by an independent group outside of the producer using industry-approved techniques. The tester verifies the cannabinoid content of the product, along with heavy metals, pesticides, or microbes. Related

How to read a CBD label

A hemp-derived CBD product that has been third-party tested also guarantees you are getting what you paid for. Leafly’s investigation on CBD tested 47 products and found that almost half of them didn’t come within 20% of the labeled dosage. Third party testing confirms that the promised CBD content is present.

You can also look for hemp-derived CBD products with a USDA organic certification. This affirms that the growing conditions meet official USDA organic standards, and also provides assurance that the hemp extraction process was free of synthetic chemical additives.

In states where cannabis-derived CBD products are available from licensed dispensaries, there is greater regulation of these products. All are subjected to stringent testing from licensed facilities.

Effectiveness

Cannabis tends to have a wider terpene and cannabinoid profile than hemp. Cannabis-derived CBD from whole plant extract contains a range of beneficial terpenes and cannabinoids, including THC. These compounds work in concert with each other to provide additional benefits. This phenomenon is known as the entourage effect, and many cannabis experts assert that whole plant extracts offer greater therapeutic potential.

Hemp also contains some cannabinoids and terpenes, but not the range nor concentration of compounds present in cannabis. Hemp-derived CBD can be made into an full-spectrum extract that offers natural terpenes alongside minor cannabinoids. Broad-spectrum CBD is also available and contains minor cannabinoids and terpenes, but without the THC content.

However, full-spectrum and broad-spectrum hemp-derived CBD products may not have the potency of CBD derived from cannabis because trace amounts of THC appear to be less effective in treating certain symptoms.

CBD isolate

CBD can also be extracted from both hemp and cannabis to become an isolate. Isolates are identical whether derived from hemp or cannabis because they only contain CBD molecules. As there is more CBD in cannabis than hemp, it requires more hemp by dry weight to produce the same amount of CBD isolate.

CBD isolate is most commonly used in clinical trials to prove that results are linked to CBD rather than other compounds from either plant that may be present. Isolates may also be favored by those who wish to avoid THC entirely.

Source: https://www.leafly.com/news/cbd/hemp-vs-cannabis-derived-cbd-whats-the-difference

Tags: , , , , , ,
Posted in PRIMO Nutraceuticals Inc. | Comments Off on PRIMO Nutraceuticals Inc. $PRMO.ca – What’s the difference between #CBD derived from #hemp and #cannabis? $CROP.ca $VP.ca NF.ca $MCOA

NORTHBUD $NBUD.ca – #Cannabis sector mounts furious lobbying drive in Ontario; Hillier seeks clarity $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 4:50 PM on Friday, November 22nd, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

Cannabis sector mounts furious lobbying drive in Ontario; Hillier seeks clarity

  • Over the past month, lobbyists have beat a path to Ontario’s legislature to discuss – among other things related to cannabis – taxation, labor policies, law enforcement and how adult-use marijuana is sold in the province

By Matt Lamers

Punished by disappointing sales due to a lack of retail stores, the cannabis industry has been mounting a fierce lobbying drive in Ontario to reach the decisionmakers driving the province’s marijuana policies, according to records from the Office of the Integrity Commissioner.

Over the past month, lobbyists have beat a path to Ontario’s legislature to discuss – among other things related to cannabis – taxation, labor policies, law enforcement and how adult-use marijuana is sold in the province.

The records show that efforts have been made to reach Ontario’s power brokers by:

  • Aurora Cannabis
  • Aphria
  • Convenience Industry Council of Canada
  • Cronos Group
  • The Green Organic Dutchman
  • Insurance Bureau of Canada
  • LeafLink
  • Loblaw
  • Supreme Cannabis Co.
  • Truss

Meanwhile, a former member of the ruling Progressive Conservative caucus is urging the party to adopt a clearer timeline for the planned pivot to an open allocation of adult-use retail stores.

Independent MPP Randy Hillier said Ontario’s bungled cannabis policies are costing the province, and its businesses, millions in lost economic opportunities.

“Here we have a government that promotes itself as ‘open for business,’ and what is the biggest impediment in the cannabis trade right now? Government’s lack of action and preventing people (from) opening retail establishments,” the independent MPP said in an interview.

He called Ontario’s cannabis lottery a “cluster you-know-what.”

The fledgling industry has already lost out on hundreds of millions of dollars of revenue, according to Craig Wiggins, managing director of market researcher TheCannalysts.

That has caused some producers to scale back production.

Hillier called on the government to empower the Alcohol and Gaming Commission of Ontario to license cannabis stores.

“We have 24 stores in operation a year out from legalization to serve 14 million people,” he said. “Newfoundland, with a population of 500,000 people, has as many stores as Ontario. Saskatchewan has twice as many with a population of a million people.

“We’re not achieving what we set out to with the legalization of cannabis, which is to get it out of the criminal marketplace. We’re allowing the criminal marketplace to continue to thrive.”

Ontario’s recent Economic Outlook restated the commitment to “an open allocation of cannabis retail store licenses where the number of stores is limited only by market demand,” however no timeline was offered.

Hillier’s advice to legal cannabis businesses is to speak up.

“If government policies are creating barriers for your businesses, then speak out.

“Bark as loud as possible, and possibly bite. That’s what often motivates government, is fear of embarrassment and fear of having to justify their actions.”

Matt Lamers is Marijuana Business Daily’s international editor, based near Toronto, Ontario. He can be reached at [email protected].

Source: https://mjbizdaily.com/cannabis-sector-mounts-furious-lobbying-drive-in-ontario-hillier-demands-clarity/

Tags: , , , , , , , , ,
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – #Cannabis sector mounts furious lobbying drive in Ontario; Hillier seeks clarity $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

North Bud Farms $NBUD.ca Expands U.S. Presence with Acquisition of a Fully Licensed and Operational #Cannabis Farm in Salinas, California $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 8:47 AM on Friday, November 22nd, 2019
  • Bonfire Brands USA, a wholly owned subsidiary of NORTHBUD, has signed multiple definitive agreements related to its previously announced letters of intent with the Qlora Group and Monterey Holdings
  • Finalized the acquisition of an 11-acre property located at 20180 Spence Road Salinas, California
  • Property currently consists of 300,000 sq. ft. of licensable greenhouse space with 60,000 sq. ft. actively cultivating cannabis and a 2,000 sq. ft. building licensed for distribution

TORONTO, Nov. 22, 2019 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) is pleased to announce that Bonfire Brands USA (“Bonfire”), a wholly owned subsidiary of NORTHBUD, has signed multiple definitive agreements related to its previously announced letters of intent with the Qlora Group and Monterey Holdings (see September 12, 2019 press release).

Transaction Terms:

  1. Bonfire Brands USA has finalized the acquisition of an 11-acre property located at 20180 Spence Road Salinas, California from Monterey Holdings Inc. The property currently consists of 300,000 sq. ft. of licensable greenhouse space with 60,000 sq. ft. actively cultivating cannabis and a 2,000 sq. ft. building licensed for distribution. The purchase price of the property is USD$8,000,000 which represents the fair market value of the real estate. The buyer and seller have entered into a seller carry back financing for the full purchase price.

  2. Bonfire Brands USA has signed a definitive agreement with the Qlora Group for the acquisition of cultivation, processing and distribution licenses associated to the Spence Road property. As part of this acquisition Bonfire Brands USA also acquires all the Intellectual Property (IP) and assets related to the brands California Bud Co and Live For The Day (LFTD). The two brands combined for approximately USD$6,500,000 in unaudited sales over the past 18 months. In consideration for this acquisition Bonfire has assumed a USD$2,500,000 debt note from the Qlora Group. The debt will be settled over a 24-month period through a combination of cash and stock at the discretion of the note holder.  Immediately upon signing of the definitive agreement Bonfire will have acquired 80% ownership of the licenses with the remaining 20% to be transferred after approval from the California Cannabis Control and Licensing Bureau.

    The buyer will be taking possession of all biological assets including:
  •    6000 plants currently in the fifth week of flowering;
  • ~ 5000 plants in various stages of vegetative growth;
  • ~ 350 Lbs. of dried and harvested flower and trim; and 
  •    3000 filled vape cartridges of various strains.                                                  

“On the heels  of the historic adoption of the MORE Act, the NORTHBUD and Bonfire team is extremely proud to have finalized this agreement and how the structure allows for the acquisition to be financed from ongoing cash flow from the acquired business with minimal dilution while allowing the company to acquire what we believe to be exceptionally positioned infrastructure located in the heart of California’s Sun Belt and home to the largest cannabis cultivators in the state,” said Ryan Brown, CEO of NORTHBUD.

This infrastructure will serve as the primary operation for Bonfire Brands USA within the state of California, which is considered to be the largest cannabis market in North America valued at USD$3 billion dollars per year according to Arcview Market Research and BDS Analytics (August 2019).

“We are very pleased with the successful acquisition of the Salinas facility,” said Justin Braune, President of Bonfire Brands USA. “We have been working closely with the cultivation team at Qlora over the past two months and will immediately take over operations to begin driving revenue growth. We anticipate our first harvest within 45 days and have been actively negotiating agreements with distribution and cultivation partners whom wish to leverage our strategic infrastructure through joint venture and subletting agreements. We anticipate closing these transactions in the near future with the goal of having the California operation generating positive cash flow in the near term.”

The Transaction is a significant acquisition but will not result in a “Fundamental Change” pursuant to the policies of the CSE. NORTHBUD will be preparing the necessary corporate and securities filings in order to secure the required approvals for the Transaction.

NORTHBUD has agreed to pay up to 3% in finder fees to arm’s length parties in connection with the closing of the Transaction. The fee is payable in common shares of NORTHBUD.

The closing of the Transaction is conditional on the receipt by the parties of applicable corporate and regulatory approvals including that of the CSE.

About North Bud Farms Inc.
North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc., is pursuing a license under The Cannabis Act. The Company has built a state-of-the-art purpose-built cannabis production facility located on 135 acres of Agricultural Land in Low, Quebec, Canada. NORTHBUD through its wholly owned U.S. subsidiary, Bonfire Brands USA has acquired cannabis production facilities in California and Nevada. The Salinas, California property is located on 11 acres which currently consists of a 300,000 sq. ft. of licensable greenhouse space with 60,000 sq. ft. actively cultivating cannabis and a 2,000 sq. ft. building licensed for distribution. The Reno, Nevada property is located on 3.2 acres of land which was acquired through the acquisition of Nevada Botanical Science, Inc. a world class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation which holds medical and adult use licenses for cultivation, extraction and distribution.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation.  Forward-looking statements, including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. This press release contains forward- looking statements including those relating to projected revenue for 2020 from the Qlora cannabis farm being acquired by Bonfire, the timing of the Company’s first harvest from the farm, and the negotiation of cultivation and distribution agreements. Forward-looking statements are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements.  Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

Tags: , , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on North Bud Farms $NBUD.ca Expands U.S. Presence with Acquisition of a Fully Licensed and Operational #Cannabis Farm in Salinas, California $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

NORTHBUD $NBUD.ca – Cannabis Canada: Ontario sets plans to let private sector handle cannabis distribution $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 5:20 PM on Thursday, November 21st, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

Cannabis Canada: Ontario sets plans to let private sector handle cannabis distribution

Ontario sets plans to let private sector handle cannabis distribution  

Ontario is gradually reducing its exposure to the legal pot industry. An email obtained by BNN Bloomberg shows the province plans to allow the private sector to handle distributing cannabis from producers to retailers. The email, which was sent to Canadian licensed producers late Tuesday, shows that Ontario plans to soon adopt a new measure to allow for a “third-party centralized distribution” system. The changes follow feedback the Ontario Cannabis Store solicited from the industry last month to determine whether it should get out of its wholesale cannabis business. The email also stated that the OCS is seeking further consultation with industry participants interested in services where cannabis can be shipped directly from a cannabis producer to a retailer, sidestepping a wholesale operator entirely.

Source: https://www.bnnbloomberg.ca/cannabis-canada-1.1351119

Tags: , , , , , , , ,
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – Cannabis Canada: Ontario sets plans to let private sector handle cannabis distribution $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

NORTHBUD $NBUD.ca – Open letter to Ottawa: This one small detail is hindering the #cannabis industry’s success $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 1:48 PM on Wednesday, November 20th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

Open letter to Ottawa: This one small detail is hindering the cannabis industry’s success

The excise stamp on a package of cannabis. Industry leaders say these stamps unique to every province and territory are making it more expensive to produce, package and ship cannabis to individual markets.Darren Brown/Postmedia

The devil is in the details. It’s a common but important refrain. It reminds us how even the smallest facets of plans, processes and situations can derail large-scale efforts.

Such is the case facing Canada’s cannabis industry. The federal government currently requires that all cannabis products carry excise stamps — proof the appropriate taxes have been paid by the licensed producer — like those attached to tobacco packaging. These stamps are also unique to each province and territory.

Excise stamps have been a source of ongoing frustration since legalization

For such a small item, the stamp significantly complicates the business of providing legal cannabis to law-abiding consumers. In addition, excise stamps hinder the flow of legal cannabis across the country, leading to costly supply issues for both governments and consumers.

Excise stamps have been a source of ongoing frustration since legalization. The logistics of applying these stamps has resulted in unnecessary product delays. Likewise, when the industry is criticized for excessive packaging, it’s often the result of complying with federal cannabis packaging requirements, which include provincial/territorial excise stamps.

Logistics aside, the stamps hinder the industry’s long-term success. Requiring producers to use province/territory-specific excise stamps impedes the flow of product across the country. Aside from the complexity of per-province labelling, product that does not sell in one region cannot easily be transported to another province where demand may be higher. The labelling requirement removes licensed producers’ ability to respond in real time to changing demand, adds unnecessary complexity to product forecasting, and means jurisdictions and retailers face completely preventable product shortages. And when consumers can’t find what they want in the legal market, they turn to the unregulated market.

The administrative and production burdens of the stamp also mean that it’s more expensive to produce, package and ship cannabis to individual markets. This means it’s substantially tougher for legal producers and retailers to compete, particularly with respect to price, with the illegal cannabis market, which shoulders absolutely none of the costs imposed on the legal system. One of the primary goals of cannabis legalization was to compete with and thereby eliminate the unregulated market for cannabis. So why do we insist on requirements like a unique provincial/territorial excise stamp that prevents that competition?

The current system isn’t working because it ignores both business and market realities

No one is objecting to industry regulation. Licensed producers have complied with regulatory requirements related to production, distribution and promotion of the product — and have made the financial investments necessary to do so. Province- and territory-specific excise stamps, however, are costly and unnecessary when one national excise stamp would do. Especially in such a new industry, where the efficiency of the manufacturing process is paramount, it is not only counter-intuitive but also counter-productive to continue the practice.

The current system isn’t working because it ignores both business and market realities. We’re not the first industry to come to this realization. In fact, Canada’s alcohol industry moved away from province/territory-specific excise stamps years ago, after delivering its own regulatory impact analysis and successfully arguing the benefits of an alternative approach.

As an industry, we have heard consistently from both public and private retailers across Canada that the current system of unique stamps offers them little to no value. At least one territory has indicated it has asked the Canada Revenue Agency to allow it to use product excise stamps for another province in order to increase its ability to access additional supply. More importantly, CRA has indicated a willingness to work with the industry on a redesign of the excise stamp. That’s progress.

If we are wholly committed to the goals of a thriving industry, we need to alleviate the logistical, financial and environmental burden of monitoring these products while successfully competing with the unregulated market. We can do so in a way that is effective, safe, and benefits the industry as well as Canadian consumers. It’s time to excise multiple excise stamps and move, instead, to a national one.

Terry Booth, CEO, Aurora; Adine Carter, Chief Marketing Officer, Tilray; Nav Dhaliwal, CEO, The Supreme Cannabis Company; Greg Engel, CEO, Organigram; Torsten Kuenzlen, CEO, Sundial Growers; Csaba Reider, President, The Green Organic Dutchman; Irwin Simon, Interim CEO and Board Chair, Aphria; Sebastien St-Louis, President & CEO, HEXO; Mark Zekulin, CEO, Canopy Growth Corporation. The authors are members of the Cannabis Council of Canada, the national industry association representing the legal cannabis sector.

Source: https://business.financialpost.com/opinion/open-letter-to-ottawa-this-one-small-detail-is-hindering-the-cannabis-industrys-success

Tags: , , , , , , , ,
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – Open letter to Ottawa: This one small detail is hindering the #cannabis industry’s success $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

PRIMO Nutraceuticals Inc. $PRMO.ca – PODCAST: #Hemp, #CBD And #Cannabis With Josh Drayton And Alex Seleznov $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 10:39 AM on Wednesday, November 20th, 2019

SPONSOR:  PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

PODCAST: Hemp, CBD And Cannabis With Josh Drayton And Alex Seleznov

Summary

  • Josh Drayton is Communications and Outreach Director of the California Cannabis Industry Association, an association that collectively represents over 460 industry businesses.
  • Alex Seleznov is a board member and Treasurer for the National Hemp Association as well as founder of Advanced Extraction, a company specializing in organically produced hemp products.
  • They join the show today to discuss why everyone’s paying attention to California, the preventable vaping crisis and what it means to be in the current CBD space.

By Rena Sherbill

Topics include:

  • 6:45 – Josh has worked at CCIA for 4 years. Getting to know cannabis as an economic driver and way of life. Passionate about legalization.
  • 7:25 – Issues with California policy. Looking at the timeline. Legalized medical in 1996 but no state regulations. No statewide framework until 2013, which is when CCIA formed. 2016 adult use passed in California and the past few years have seen medical and adult use regulations being figured out. 55 bills in this year alone. Everyone’s paying attention to California but it takes being incredibly engaged.
  • 9:55 – Licensing supply and demand. Dual licensing system in California (local and state permits). Conflicting regulations in different areas.
  • 11:15 – Regulated vs. illicit shops. Lack of education about black market. Plays into the vaping crisis. Needs to improve. Deaths in California happened in banned areas from black market. War on drugs doesn’t improve public health. Legislators beginning to understand this.
  • 13:35 – Prediction for federal legality. Will California be a model? California modeled itself on other successful markets and has gone above and beyond in regards to packaging and testing regulations. Federal government is watching California. Canada, France, New Zealand, Germany regulators all have toured California to see how their cannabis market works. SAFE Banking Act a huge catalyst. Regulating gives more control, not less.
  • 15:23 – Farm Bill passing, CBD proliferation has helped THC market. Medical conversations help with cannabis and hemp markets.
  • 16:40 – Investors interested in getting into the space – everyone needs to understand it’s a marathon, not a sprint. The longer the legal market exists the more it’s going to pay off.
  • 17:25 – Alex’s company Advanced Extractions. Vertically integrated hemp/CBD company based in Colorado.
  • 18:25 – Confusion around passage of Farm Bill in CBD space. What it means to be in the CBD space right now. Lack of regulation means people are interpreting rules on their own. Lots of opportunity.
  • 19:49 – What do investors and consumers need to look for in this space? Investors need to vet claims a company makes. Only FDA demand is on claims. Transparency is key as well as evidence of regulatory compliance. Market is subject to scrutiny that no other product – no matter how harmful – is subject to.
  • 22:05 – Differentiation in a saturated market. Restricted marketplace gives opportunity for brands to find their niche.
  • 23:52 – Future of hemp space. Total plant purposes of hemp. Putting more renewables into the consumer stream. Alternative to plastic. Initially there will be more of a ceiling before it’s able to become a mass market product.

Source: https://seekingalpha.com/article/4307958-hemp-cbd-cannabis-josh-drayton-alex-seleznov

Tags: , , , , , , ,
Posted in PRIMO Nutraceuticals Inc. | Comments Off on PRIMO Nutraceuticals Inc. $PRMO.ca – PODCAST: #Hemp, #CBD And #Cannabis With Josh Drayton And Alex Seleznov $CROP.ca $VP.ca NF.ca $MCOA

Empower $CBDT.ca launches #CBD product sales strategy in California and provides progress report on Heritage Joint Venture for Extraction and Production Facility in Oregon $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 8:39 AM on Wednesday, November 20th, 2019
  • Company has launched commissioned based sales personnel and an influencer strategy for it’s Sollievo CBD line in Southern California
  • In addition, the Heritage CSE: CANN previously announced proposed joint venture initiative, is proceeding forward as planned with the definitive agreement drafting taking place and facility and equipment procurement plans underway.

VANCOUVER, Nov. 20, 2019 - EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt 8EC) (OTC: EPWCF) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics in the U.S., is pleased to announce the Company has launched commissioned based sales personnel and an influencer strategy for it’s Sollievo CBD line in Southern California. In addition, the Heritage CSE: CANN previously announced proposed joint venture initiative, is proceeding forward as planned with the definitive agreement drafting taking place and facility and equipment procurement plans underway.

The California population is 39,557,045 people according to the US Census Bureau’s 2018 Population Estimates Program making it the most populated state in the U.S. Los Angeles County, Orange County and Ventura County have a combined population of 14,149,511 consumers making it one of the most densely populated regions of the entire country.

The California Cannabis Portal indicates there are over 170 dispensaries in Los Angeles County that our sales agents are canvassing and bringing Sollievo product samples too. They are also talking to various smoke shops, vape stores and a variety of retail locations that carry CBD products or have expressed an interest to sell CBD products.

“Establishing a retail presence in this area for our Sollievo CBD product lines gives us significant volume potential, but also provides crucial market feedback about branding, product quality and consumer adoption.” said Steven McAuley, Empowers Chairman and CEO. “Gaining direct market feedback, by having our own sales agents on the ground is already proving beneficial.”

Heritage Cannabis JV Update

  • The previously announced Empower Clinics and Heritage Cannabis JV announcement from September 17th, 2019 is continuing forward as planned with a variety of actions being completed by both Parties.

  • Documentation of the Definitive Agreement for the joint venture is underway, and progress is expected to be reported by the Companies in the near future.

  • Graeme Staley, the CEO of Purefarma and Board of Directors member for Heritage Cannabis, completed a site visit of the Sandy, OR facility located on the SE side of Portland, Oregon with Empowers Chairman & CEO Steven McAuley.

  • The site visit solidified the importance of the new 5,000 sq. ft. facility secured by Empower, and the fact that the Oregon Department of Agriculture Hemp Handlers Licence has been issued.

  • Both Empower and Heritage believe operating in a low-cost region like Oregon provides a competitive advantage with direct access to the farming supply chain for the some of the best hemp biomass in the entire country.

  • Local facility and labor costs are competitive on a national scale, and with a skilled and passionate local workforce, the joint venture has the opportunity to provide high quality long-term jobs for the local economy of Sandy, OR, Clackamas County and surrounding regions.

ABOUT EMPOWER

Empower is a vertically integrated and growth-oriented CBD life sciences company, and a multi-state operator of medical health & wellness clinics, operating the Sun Valley Health clinic brand www.sunvalleyhealth.com, for its nine corporate locations and for franchises in the United States. As a CBD product manufacturer under the Sollievo brand, the Company distributes its lines through clinics, online and through retail partners. Extraction operations are currently being developed in the Company’s new extraction facility in Oregon.

ABOUT HERITAGE

The Company is a vertically integrated cannabis provider that currently has two Health Canada approved licenced producers, through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp. both regulated under the Cannabis Act Regulations. Working under these two licences, Heritage has two additional subsidiaries, Purefarma Solutions, which provides extraction services, and BriteLife Sciences that is focused on cannabis based medical solutions. Heritage as the parent Company, is focused on providing resources for its subsidiaries to advance their products or services to compete both domestically and internationally.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the terms of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empowers patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that the hemp-based CBD extraction facility may not be fully operational in 2019 if at all; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE Empower Clinics Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2019/20/c5617.html

CONTACTS: Investors: Steve Low, Boom Capital Markets, [email protected], 647-620-5101; Investors: Steven McAuley, CEO, [email protected], 604-789-2146; For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARICopyright CNW Group 2019

Tags: , , , , , ,
Posted in Empower Clinics Inc. | Comments Off on Empower $CBDT.ca launches #CBD product sales strategy in California and provides progress report on Heritage Joint Venture for Extraction and Production Facility in Oregon $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

INTERVIEW: Empower Clinics $CBDT.ca Bucks #Cannabis Downfall With 137% Increase In Revenue, 211% Increase In Patient Visits $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 5:10 PM on Tuesday, November 19th, 2019

Empower Clinics JV Could Generate $US 30,000,000 In Annual Revenue From CBD Extraction … But It Doesn’t End There

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for.  Add in the fact it is now on a ~ $USD 4,000,000 annualized revenue run rate for 2019 and it becomes the kind of company small cap investors have been dying to find as they watch pretender companies melt away.

But it doesn’t end there.

The Company’s latest Q3 financials show that Empower is in full growth mode, with substantial increases in revenue and patient visits, as well as, big reductions in expenses.  Moreover, Company CEO Steven McAuley says growth will continue full steam ahead in Q4, Q1 and beyond.

But it doesn’t end there. 

CBD extraction has been a key element of the company’s vertical integration. Producing its’ own hemp-derived CBD products for its own massive patient list just makes sense. However, thanks to an LOI (moving towards definitive agreement) to JV with extraction experts Heritage Cannabis, the Company’s 5,000 sq ft facility in Oregon is also planning to serve big brand 3rd party partners in the USA .  Empower brings the infrastructure, Heritage brings the expertise and balance sheet.  The result is a match made in shareholder heaven with initial annual capacity of 6,000 Kg at ~ $US 5,000 per Kg, which adds up to $US 30,000,000 in potential revenue.

We emphasize potential  because nobody has started selling anything yet but the facility is expected to begin producing soon.  However, with a built in patient database and talks already having commenced for white label products, Empower is on its way.  Moreover, “potential” cuts both ways, with capacity capable of increasing 2x – 3x without much trouble given the size of the facility.  

Can Empower successfully execute its extraction plan?  It’s a legitimate question, with a blow away answer..
The Company’s new CEO, Steven McAuley, who replaced the previous management team in January, is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which also explains how McAuley has brought Empower to such heights in just 11 months.

The cannabis market is currently throwing away babies with the bathwater – but just as the dot-com crash brought us massive riches through Web 2.0 companies that were REAL, investors need to start looking for the REAL companies that will survive and thrive.  With 165,000 patients, rapidly increasing revenues, a franchise plan to grow clinics across America and a vertical integration CBD extraction strategy to tie them all together, Empower Clinics may be such a company.  

Grab your favourite beverage and settle in to watch what may be your next great small cap investment.

Tags: , , , , , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, Empower Clinics Inc. | Comments Off on INTERVIEW: Empower Clinics $CBDT.ca Bucks #Cannabis Downfall With 137% Increase In Revenue, 211% Increase In Patient Visits $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

North Bud Farms $NBUD.ca Enters U.S. Market with the Signing of the Definitive Agreement to Acquire Nevada Botanical Science Located in Reno, Nevada $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 8:59 AM on Tuesday, November 19th, 2019
  • Signed a definitive asset purchase agreement to acquire all assets of Nevada Botanical Science, Inc.
  • Transaction valued at USD$7.5 million
  • NBS currently operates a 5,000 sq. ft. indoor cultivation facility and has been approved for expansion of up to 60,000 sq. ft of greenhouse space.
  • Property also includes an operating extraction facility and licensed and approved commercial kitchen.
  • This infrastructure is capable of manufacturing and bottling beverages and edibles and is currently used by NBS for both white label and branded product manufacturing.

TORONTO, Nov. 19, 2019 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company”) is pleased to announce that Bonfire Brands USA, a wholly owned subsidiary of NORTHBUD, has signed a definitive asset purchase agreement to acquire all assets of Nevada Botanical Science, Inc. (“NBS”) (see June 25, 2019 press release) in a transaction valued at USD$7.5 million.

Nevada Botanical Science (NBS) is located in Reno, Nevada. NBS holds Nevada State medical and adult use licenses for cultivation, extraction and distribution. NBS operates an integrated cannabis operation located on 3.2 acres of land within the Reno green zone industrial park. NBS currently operates a 5,000 sq. ft. indoor cultivation facility and has been approved for expansion of up to 60,000 sq. ft of greenhouse space. The property also includes an operating extraction facility and licensed and approved commercial kitchen. This infrastructure is capable of manufacturing and bottling beverages and edibles and is currently used by NBS for both white label and branded product manufacturing. Operated by healthcare professionals, NBS has been primarily focused on the Nevada State medical cannabis market. NBS currently manufactures and sells award winning (Jack Herer Cup 2018) topical pain creams, balms and lotions under the Trichomic medical brand.

This past year NBS launched a trial release of cannabis infused cocktails under the brand “Happiest Hour”. Collaborating with local craft beverage manufactures NBS released a variety of beverages including Margarita, Pina Colada, Bloody Mary, Long Island Ice Tea and Lemonade to select retailers in the state. To date retailer adoption and reordering has been 100% and based on customer feedback, NBS will increase production and distribution including additional retailers in Las Vegas in 2020. NBS has also finished a successful trial launch of its energy shot 1oz beverage containing 25mg of THC and 50mg of Caffeine. The Company plans to run a second branded trial in early 2020. Over the past three months NBS and NORTHBUD have been working together in preparation for the release of NORTHBUD branded dried flower products in Q4 2019 and a variety of infused and non-infused pre rolls. 

“Subject to the finalizing of the previously announced acquisition of the Qlora Group in California, the Company plans to establish a unified product manufacturing and distribution platform within these two important states,” said Justin Braune, President of Bonfire Brands USA. “The license classes in California and Nevada allow for identical activities and the Company has been in negotiation with multiple potential JV partners who wish to leverage this unique platform. Being one of the few multi state operators with operations in both states will allow us to offer turnkey solutions to prospective partners moving forward.”

Transaction Terms

The transaction (the “Transaction”) is structured as an asset purchase agreement whereby in exchange for the purchase of all of the securities and assets of NBS, NORTHBUD is paying a total of USD$7,500,000 as follows:

  • Cash payment of USD$500,000 (paid in full);
  • Approximately USD$1 million in convertible shares of Bonfire Brands USA (6,500,000 “convertible shares”); and
  • A USD$6,000,000 interest bearing promissory note.

The convertible shares may be exchanged on a 1-1 basis with common shares of NBUD at the discretion of the shareholder. At the time of signing, the converted value of these securities was equal to USD$1,000,000. All applicable U.S. and Canadian regulatory holds shall apply upon conversion.

As per the terms of the agreement NBS will allocate pro rated ownership of assets in NBS and all associated licenses to Bonfire Brands USA throughout the re-payment period, subject to state approval.

Bonfire Brands and NBS have agreed to an operations and management arrangement allowing Bonfire to assume operational control, begin integration and driving revenue immediately.  

“The NORTHBUD and Bonfire Brands USA team are extremely proud to have finalized this agreement making the state of Nevada our strategic entry point into the U.S. legal cannabis market,” said Ryan Brown, CEO of NORTHBUD. “We are equally proud of the structure of the deal and how it minimizes shareholder dilution while allowing our team to begin integration and operations with a focus on immediate revenue growth in one of the most sought-after adult use markets in North America. Our team has been looking at acquisitions in Nevada for over two years before finding the right fit.  The Nevada market is considered one of the largest and most profitable in North America with recreational sales of USD$580 million in the first full year of legalization* (2017 Nevada Dept. of Taxation).”

The securities of the Company have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws. Accordingly, the securities of the Company may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful.

The Transaction is a significant acquisition but will not result in a “Fundamental Change” pursuant to the policies of the CSE. NORTHBUD will be preparing the necessary corporate and securities filings in order to secure the required approvals for the Transaction.

The parties have agreed to pay USD$187,500 in broker/finder fees to arm’s length parties on a prorated basis connection with the closing of the Transaction.

The closing of the Transaction is conditional on the receipt by the parties of applicable corporate and regulatory approvals, including that of the CSE.

About Nevada Botanical Science, Inc.

Founded by a group of northern Nevada physicians and healthcare professionals who believe in the promise of medical cannabis, Nevada Botanical Science has developed a world class cannabis production, research and development facility in Reno’s Washoe County. Its work and commitment are fully in compliance with the Hippocratic Oath as well as Nevada statute. Nevada Botanical Science is dedicated to ensuring the highest measure of safety, governance and stewardship for its patients, employees and the community it serves.

For more information visit: www.nevadabotanicalscience.com

About North Bud Farms Inc.

North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc., is pursuing a licence under The Cannabis Act.  The Company has built a state-of-the-art purpose-built cannabis production facility located on 135 acres of Agricultural Land in Low, Quebec, Canada. NORTHBUD through its wholly owned U.S. subsidiary, Bonfire Brands USA has acquired Nevada Botanical Science, Inc. a world class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation in Reno’s Washoe County. Nevada Botanical Science holds medical and adult use licenses for cultivation, extraction and distribution. Bonfire Brands USA has entered into an agreement to acquire assets in Salinas, California.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation.  Forward-looking statements, including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. This press release contains forward- looking statements including those relating to the entering into of the Definitive Agreement and closing of the Transaction with Nevada Botanical Science, Inc. Forward-looking statements are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements.  Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

Tags: , , , , , , , ,
Posted in All Recent Posts, Featured, North Bud Farms Inc | Comments Off on North Bud Farms $NBUD.ca Enters U.S. Market with the Signing of the Definitive Agreement to Acquire Nevada Botanical Science Located in Reno, Nevada $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

NORTHBUD $NBUD.ca – #THC – infused #edibles and #CBD – infused edibles $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

Posted by AGORACOM-JC at 5:37 PM on Monday, November 18th, 2019

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

THC-infused edibles and CBD-infused edibles

When cannabis is ingested, the THC is metabolized by the liver

With edibles coming to brick-and-mortar shops in mid-December, users are looking to get high without the smoke.

But when choosing edibles, users will want to pay attention to whether the product has CBD or THC, two compounds with very different effects.

CBD

CBD, the non-psychoactive component within cannabis has been widely touted for its medical benefits to help people with, among other conditions, chronic pain. The World Health Organization (WHO) reports CBD is not physically addictive.

By comparing those administered doses of active CBD to those given as a placebo, researchers said that “while the number of studies is limited, the evidence from well-controlled human experimental research indicates that CBD is not associated with abuse potential.”

CBD leads to slower effects that aren’t psychoactive in nature — meaning they aren’t the effects you see portrayed in pop culture.

The effects from CBD will be tame and mellow compared to its psychoactive opposite, THC. Most medical cannabis includes CBD rather than THC, with CBD already available in capsule form in legal stores.

THC

When most people think of cannabis’ effects, they think of THC. Many of the new cannabis products slated to enter stores in mid-December will focus on THC.

When cannabis is ingested, the THC is metabolized by the liver, transforming itself into 11-hydroxy-THC. This metabolite is up to four times faster in crossing the blood-brain barrier than average THC, and is why edibles are associated with intense, vivid and longer-lasting experiences.

THC normally gets pointed at as the compound that creates the potential for withdrawal symptoms among some heavy users.

An evidence brief compiled by the Canadian Public Health Association (CPHA) states that “cannabis is addictive, though not everyone who uses it will develop an addiction.”

While using cannabis oil or edibles with THC, users may get addicted or experience habit-formation. Products that only include CBD don’t appear to become addictive.

Source: https://lfpress.com/cannabis-news/day-29-thc-infused-edibles-and-cbd-infused-edibles/wcm/473a4264-5028-4c42-94ca-53da8b2db7c7

Tags: , , , , , , , ,
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – #THC – infused #edibles and #CBD – infused edibles $CGC $ACB $APH $CRON.ca $HEXO.ca $TRST.ca $OGI.ca

« Older Entries
Newer Entries »